BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Leung C, Yeoh SW, Patrick D, Ket S, Marion K, Gow P, Angus PW. Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. World J Gastroenterol 2015; 21(4): 1189-1196 [PMID: 25632192 DOI: 10.3748/wjg.v21.i4.1189]
URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1189.htm
(318) (355) (0) (0) (8360) (97)
Number Citing Articles
1
N. Golse, A. El Bouyousfi, F. Marques, B. Bancel, K. Mohkam, C. Ducerf, P. Merle, M. Sebagh, D. Castaing, A. Sa Cunha, R. Adam, D. Cherqui, E. Vibert, J.-Y. Mabrut. Large hepatocellular carcinoma: Does fibrosis really impact prognosis after resection?. Journal of Visceral Surgery 2018; 155(4) doi: 10.1016/j.jviscsurg.2017.10.015
2
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li. The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis. Hepatology 2019; 70(3) doi: 10.1002/hep.30506
3
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2024; 22(9) doi: 10.1016/j.cgh.2024.03.028
4
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liver. Clinical Hemorheology and Microcirculation 2022; 80(4) doi: 10.3233/CH-211309
5
Non-Neoplastic Diseases of the Liver. 2022;  doi: 10.55418/9781933477183-9
6
Ziwei Li, Dongyu Duan, Li Li, Dan Peng, Yue Ming, Rui Ni, Yao Liu. Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1382256
7
Stefano Bellentani, Gianluca Svegliati Baroni, Fabio Piscaglia, Claudio Tiribelli. Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma. Clinical Liver Disease 2016; 8(4) doi: 10.1002/cld.582
8
Luis Calzadilla Bertot, Leon A Adams. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(2) doi: 10.1080/17474124.2019.1549989
9
Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana Alcantara Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei-Jer Chen, Cosmas Rinaldi A. Lesmana, Laurentius A. Lesmana, Rino A. Gani, Shuntaro Obi, A. Kadir Dokmeci, Shiv Kumar Sarin. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology International 2017; 11(4) doi: 10.1007/s12072-017-9799-9
10
Margarita N. German, Megan K. Lutz, Perry J. Pickhardt, Richard J. Bruce, Adnan Said. Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8) doi: 10.1097/MCG.0000000000001260
11
Talya L. Dayton, Vasilena Gocheva, Kathryn M. Miller, William J. Israelsen, Arjun Bhutkar, Clary B. Clish, Shawn M. Davidson, Alba Luengo, Roderick T. Bronson, Tyler Jacks, Matthew G. Vander Heiden. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development 2016; 30(9) doi: 10.1101/gad.278549.116
12
Dalbir Singh Sandhu, Jin-Ping Lai, Sonia Sandhu, Aakash Desai. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
13
Mingyue Song, Yuhao Tao, Hanjun Zhang, Mingzhan Du, Lingchuan Guo, Chunhong Hu, Weiguo Zhang. Gd-EOB-DTPA-enhanced MR imaging features of hepatocellular carcinoma in non-cirrhotic liver. Magnetic Resonance Imaging 2024; 114 doi: 10.1016/j.mri.2024.110241
14
进玲 刘. Serological Biomarkers Related to Non-Cirrhotic Hepatocellular Carcinoma: Promising Applications in Clinical Diagnosis and Prognosis. Advances in Clinical Medicine 2025; 15(02) doi: 10.12677/acm.2025.152327
15
Luis Calzadilla Bertot, Leon Adams. The Natural Course of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(5) doi: 10.3390/ijms17050774
16
Marta Romero-Gutiéttez, María Abadanes Tercero, Juan Ruiz Martín, Juan Diego Castro Limo, Tomás Artaza Varasa, Concepción González de Frutos, Gema de la Cruz Pérez, Juan José Sánchez Ruano, Ana Zaida Gómez Moreno, Rafael Gómez Rodríguez. Characteristics and survival of hepatocellular carcinoma in non-cirrhotic liver.. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6180/2018
17
Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, Victor Sapena, Nicola Colucci, Ferran Torres, Jordi Bruix, María Reig, Christian Toso. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clinical Gastroenterology and Hepatology 2022; 20(2) doi: 10.1016/j.cgh.2021.05.002
18
Marcus J. Lyall, John P. Thomson, Jessy Cartier, Raffaele Ottaviano, Timothy J. Kendall, Richard R. Meehan, Amanda J. Drake. Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation. Epigenetics 2020; 15(1-2) doi: 10.1080/15592294.2019.1649527
19
Marcus J. Lyall, Jessy Cartier, James A Richards, Diego Cobice, John P Thomson, Richard R Meehan, Stephen M Anderton, Amanda J Drake. Methyl donor deficient diets cause distinct alterations in lipid metabolism but are poorly representative of human NAFLD. Wellcome Open Research 2017; 2 doi: 10.12688/wellcomeopenres.12199.1
20
Bjarki Sigurdsson, Ragna Sigurdardottir, Margret B. Arnardottir, Sigrun H. Lund, Jon G. Jonasson, Einar S. Björnsson. A nationwide study on hepatocellular carcinoma. Cancer Epidemiology 2020; 69 doi: 10.1016/j.canep.2020.101835
21
Makiko Taniai, Etsuko Hashimoto, Maki Tobari, Kazuhisa Kodama, Katsutoshi Tokushige, Masakazu Yamamoto, Tadatoshi Takayama, Masahiko Sugitani, Keiji Sano, Fukuo Kondo, Toshio Fukusato. Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma‐related markers. Hepatology Research 2018; 48(12) doi: 10.1111/hepr.13203
22
Mohamed G Shoreibah, Brendan M McGuire, Omar I Massoud, Meagan E Gray, Ross M Hansen, Patrick S Harris. Hepatocellular carcinoma surveillance: An evidence-based approach. World Journal of Gastroenterology 2019; 25(13): 1550-1559 doi: 10.3748/wjg.v25.i13.1550
23
Thai P Hong, Paul J Gow, Michael Fink, Anouk Dev, Stuart K Roberts, Amanda Nicoll, John S Lubel, Ian Kronborg, Niranjan Arachchi, Marno Ryan, William W Kemp, Virginia Knight, Vijaya Sundararajan, Paul Desmond, Alexander JV Thompson, Sally J Bell. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population‐based study. Medical Journal of Australia 2018; 209(8) doi: 10.5694/mja18.00373
24
Xuan-vinh Kevin Nguyen, Jason Zhang, Ken Lee Chin, Stephen Bloom, Amanda J. Nicoll. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?. Nutrients 2022; 14(18) doi: 10.3390/nu14183875
25
Jose Tadeu Stefano, Fernanda de Mello Malta, Priscila Brizola de Campos, Pedro Fernandes Andrade, Denise Cerqueira Paranaguá-Vezzozo, Flair Jose Carrilho, Claudia P. Oliveira. NAFLD and NASH. 2020;  doi: 10.1007/978-3-030-37173-9_11
26
Pierre Bedossa, Valérie Paradis. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017;  doi: 10.1016/B978-0-323-34062-5.00089-3
27
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
28
Ahmet Uygun. Is That Possible to Stop or Cease the NASH to Turn into HCC?. Journal of Gastrointestinal Cancer 2017; 48(3) doi: 10.1007/s12029-017-9961-6
29
Sayantan Ray, Rajan Palui, Partha Pal. Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. World Journal of Hepatology 2021; 13(11): 1584-1610 doi: 10.4254/wjh.v13.i11.1584
30
Guozhen Cui, Robert C. Martin, Hang Jin, Xingkai Liu, Harshul Pandit, Hengjun Zhao, Lu Cai, Ping Zhang, Wei Li, Yan Li. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0781-8
31
Samer Gawrieh, Lara Dakhoul, Ethan Miller, Andrew Scanga, Andrew deLemos, Carla Kettler, Heather Burney, Hao Liu, Hamzah Abu‐Sbeih, Naga Chalasani, Julia Wattacheril. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Alimentary Pharmacology & Therapeutics 2019; 50(7) doi: 10.1111/apt.15464
32
Cristina Margini, Jean F. Dufour. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver International 2016; 36(3) doi: 10.1111/liv.13031
33
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
34
Yuanliang Xie, Hongfeng Zhang, Chaoling Jin, Xiang Wang, Xiaoqi Wang, Jingting Chen, Yikai Xu. Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits. Magnetic Resonance Imaging 2018; 48 doi: 10.1016/j.mri.2017.12.017
35
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.11.001
36
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li. Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Medicinal Research Reviews 2019; 39(1) doi: 10.1002/med.21515
37
Javier Martinez-Useros, Jesus Garcia-Foncillas. Obesity and colorectal cancer: molecular features of adipose tissue. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0772-5
38
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68(2) doi: 10.1002/hep.29913
39
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 157(2) doi: 10.1093/ajcp/aqab125
40
Vincent Chiu, Christine Yee, Nathan Main, Igor Stevanovski, Matthew Watt, Trevor Wilson, Peter Angus, Tara Roberts, Nicholas Shackel, Chandana Herath. Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model. Clinical Science 2024; 138(19) doi: 10.1042/CS20240560
41
Andrea Marengo, Chiara Rosso, Elisabetta Bugianesi. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.  Annual Review of Medicine 2016; 67(1) doi: 10.1146/annurev-med-090514-013832
42
Jessica Howell, Amit Samani, Binish Mannan, Saur Hajiev, Leila Motedayen Aval, Rebecca Abdelmalak, Vincent C. Tam, Dominik Bettinger, Robert Thimme, Tamar H. Taddei, David E. Kaplan, Max Seidensticker, Rohini Sharma. Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221100106
43
Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca, Ester Vanni, Stefania Grimaudo, Renato Romagnoli, Fabio Colli, Flaminia Ferri, Rosellina Margherita Mancina, Paula Iruzubieta, Antonio Craxi, Anna Ludovica Fracanzani, Antonio Grieco, Stefano Ginanni Corradini, Alessio Aghemo, Massimo Colombo, Giorgio Soardo, Elisabetta Bugianesi, Helen Reeves, Quentin M. Anstee, Silvia Fargion, Luca Valenti. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04991-0
44
Bashar Mohamad, Vaishal Shah, Mykola Onyshchenko, Mohammed Elshamy, Federico Aucejo, Rocio Lopez, Ibrahim A. Hanouneh, Razan Alhaddad, Naim Alkhouri. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatology International 2016; 10(4) doi: 10.1007/s12072-015-9679-0
45
Umut Aykutlu, Asuman Argon, Mehmet Orman, Sezgin Ulukaya, Murat Zeytunlu, Zeki Karasu, Fulya Günşar, Deniz Nart, Ulus Akarca, Funda Yilmaz. Steatotic and Steatohepatitic Hepatocellular Carcinomas. American Journal of Surgical Pathology 2021; 45(9) doi: 10.1097/PAS.0000000000001714
46
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
47
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020586
48
Heinz Zoller, Herbert Tilg. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2016.01.010
49
Dzeina Mezale, Ilze Strumfa, Andrejs Vanags, Matiss Mezals, Ilze Fridrihsone, Boriss Strumfs, Dainis Balodis. Liver Cirrhosis - Update and Current Challenges. 2017;  doi: 10.5772/intechopen.68771
50
Marcus J. Lyall, Jessy Cartier, John P. Thomson, Kate Cameron, Jose Meseguer-Ripolles, Eoghan O'Duibhir, Dagmara Szkolnicka, Baltasar Lucendo Villarin, Yu Wang, Giovanny Rodriguez Blanco, Warwick B. Dunn, Richard R. Meehan, David C. Hay, Amanda J. Drake. Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. Philosophical Transactions of the Royal Society B: Biological Sciences 2018; 373(1750) doi: 10.1098/rstb.2017.0362
51
Michael A. Nalesnik. Hepatocellular Carcinoma. 2016;  doi: 10.1007/978-3-319-34214-6_20
52
Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics 2020; 10(8) doi: 10.3390/diagnostics10080579
53
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Digestive Diseases and Sciences 2022; 67(6) doi: 10.1007/s10620-021-07048-5
54
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki. Role of Insulin Resistance in MAFLD. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084156
55
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Reports 2021; 3(4) doi: 10.1016/j.jhepr.2021.100305
56
Emine Turkmen Samdanci. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022;  doi: 10.5772/intechopen.99842
57
Xinyue Lin, Juanhong Zhang, Yajun Chu, Qiuying Nie, Junmin Zhang. Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacology & Therapeutics 2024; 254 doi: 10.1016/j.pharmthera.2024.108593
58
Monika Vyas, Dhanpat Jain. A practical diagnostic approach to hepatic masses. Indian Journal of Pathology and Microbiology 2018; 61(1) doi: 10.4103/IJPM.IJPM_578_17
59
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison. NAFLD‐related hepatocellular carcinoma: The growing challenge. Hepatology 2023; 77(1) doi: 10.1002/hep.32542
60
Maddalena Parafati, Sang Hyo Bae, R. Jason Kirby, Martina Fitzek, Preeti Iyer, Ola Engkvist, David M. Smith, Siobhan Malany. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation. International Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249557
61
Matthew M. Yeh, Yajuan Liu, Michael Torbenson. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. Human Pathology 2015; 46(11) doi: 10.1016/j.humpath.2015.07.018
62
Muhammad Imran Ahmad, Muhammad Umair Khan, Sudha Kodali, Akshay Shetty, S Michelle Bell, David Victor. Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges. Journal of Hepatocellular Carcinoma 2022;  doi: 10.2147/JHC.S344559
63
Francesco Izzo, Meredith C. Mason, Eric J. Silberfein, Nader N. Massarweh, Cary Hsu, Hop S. Tran Cao, Raffaele Palaia, Mauro Piccirillo, Andrea Belli, Renato Patrone, Roberta Fusco, Vincenza Granata, Steven A. Curley. Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening. Biology 2022; 11(11) doi: 10.3390/biology11111597
64
Maria Reig, Martina Gambato, Nancy Kwan Man, John P. Roberts, David Victor, Lorenzo A. Orci, Christian Toso. Should Patients With NAFLD/NASH Be Surveyed for HCC?. Transplantation 2019; 103(1) doi: 10.1097/TP.0000000000002361
65
Amir Sultan, Chimaobi M. Anugwom, Zerihun Wondifraw, Grace A. Braimoh, Abate Bane, Jose D. Debes. Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa. Expert Review of Gastroenterology & Hepatology 2020; 14(10) doi: 10.1080/17474124.2020.1802246
66
N. Golse, A. El Bouyousfi, F. Marques, B. Bancel, K. Mohkam, C. Ducerf, P. Merle, M. Sebagh, D. Castaing, A. Sa Cunha, R. Adam, D. Cherqui, E. Vibert, J.-Y. Mabrut. Volumineux carcinome hépatocellulaire : quel est l’impact de la fibrose sur le pronostic après résection ?. Journal de Chirurgie Viscérale 2018; 155(4) doi: 10.1016/j.jchirv.2017.09.005
67
Marie Boyle, Quentin M. Anstee. Evidence‐based Gastroenterology and Hepatology 4e. 2019;  doi: 10.1002/9781119211419.ch35
68
Florian Koutny, Elmar Aigner, Christian Datz, Sophie Gensluckner, Andreas Maieron, Andrea Mega, Bernhard Iglseder, Patrick Langthaler, Vanessa Frey, Bernhard Paulweber, Eugen Trinka, Bernhard Wernly. Relationships between education and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2023; 118 doi: 10.1016/j.ejim.2023.07.039
69
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology 2017; 4(3) doi: 10.2217/hep-2017-0013
70
Marie Boyle, Quentin M. Anstee. Editorial: hepatocellular carcinoma in non‐cirrhotic NASH—a troubling reality. Alimentary Pharmacology & Therapeutics 2018; 48(9) doi: 10.1111/apt.14982
71
Erin M. Sadler, Neil Mehta, Mamatha Bhat, Anand Ghanekar, Paul D. Greig, David R. Grant, Francis Yao, Gonzalo Sapisochin. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma. Transplantation 2018; 102(4) doi: 10.1097/TP.0000000000002043
72
Harshul Pandit, Yan Li, Qianqian Zheng, Wei Guo, Youxi Yu, Suping Li, Robert C.G. Martin. Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice. Oncotarget 2020; 11(22) doi: 10.18632/oncotarget.27454
73
Shiv Chitturi, Vincent Wai‐Sun Wong, Wah‐Kheong Chan, Grace Lai‐Hung Wong, Simon Kin‐Hung Wong, Jose Sollano, Yen‐Hsuan Ni, Chun‐Jen Liu, Yu‐Cheng Lin, Laurentius Adrianto Lesmana, Seung Up Kim, Etsuko Hashimoto, Masahide Hamaguchi, Khean‐Lee Goh, Jiangao Fan, Ajay Duseja, Yock Young Dan, Yogesh Chawla, Geoff Farrell, Henry Lik‐Yuen Chan. The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups. Journal of Gastroenterology and Hepatology 2018; 33(1) doi: 10.1111/jgh.13856
74
Sui‐Weng Wong, Yi‐Wen Ting, Wah‐Kheong Chan. Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications. JGH Open 2018; 2(5) doi: 10.1002/jgh3.12070
75
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5) doi: 10.26442/20751753.2023.5.202272
76
Rupie Jamwal, Venkatram Krishnan, Dinesh Singh Kushwaha, Rajat Khurana. Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysis. Abdominal Radiology 2020; 45(8) doi: 10.1007/s00261-020-02561-z
77
Nikolaos-Andreas T. Anastasopoulos, Georgios D. Lianos, Vera Tatsi, Anastasia Karampa, Anna Goussia, Georgios K. Glantzounis. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(11) doi: 10.1080/17474124.2020.1802244
78
Monika Vyas, Xuchen Zhang. Practical Liver Pathology. Practical Anatomic Pathology 2025;  doi: 10.1007/978-3-031-97506-6_18
79
Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Hideki Takami, Yoshikuni Inokawa, Fuminori Sonohara, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences. Nutrition and Cancer 2021; 73(6) doi: 10.1080/01635581.2020.1779758
80
Marco Castellana, Rossella Donghia, Luisa Lampignano, Fabio Castellana, Roberta Zupo, Rodolfo Sardone, Giovanni De Pergola, Gianluigi Giannelli. Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma. Journal of Clinical Medicine 2021; 10(20) doi: 10.3390/jcm10204638
81
Jialu Yang, Huimin Xu, Yijun Zhao, Pengju Sun, Yuanyuan Li, Ting Chen, Yanmei Zhou. Bivariate tracking of NIR phototherapeutic probe that illuminates the deterioration process of NAFLD-HCC. Biosensors and Bioelectronics 2025; 269 doi: 10.1016/j.bios.2024.116967
82
Chuanzheng Sun, Xunyang Liu, Zhongjie Yi, Xuefei Xiao, Mingshi Yang, Gui Hu, Huaizheng Liu, Liangkan Liao, Feizhou Huang. Genome‐wide analysis of long noncoding RNA expression profiles in patients with non‐alcoholic fatty liver disease. IUBMB Life 2015; 67(11) doi: 10.1002/iub.1442
83
Sarah Da Won Bae, Jacob George, Liang Qiao. From MAFLD to hepatocellular carcinoma and everything in between. Chinese Medical Journal 2022; 135(5) doi: 10.1097/CM9.0000000000002089
84
Giuseppe Losurdo, Antonino Castellaneta, Claudia Di Nuccio, Paola Dell’Aquila, Ilaria Ditonno, Domenico Novielli, Antonio Continisio, Margherita De Bellis, Alfredo Di Leo, Mariabeatrice Principi, Michele Barone. Comparison Between Transient Elastography and Point Shear Wave Elastography in the Assessment of Liver Fibrosis According to the Grade of Liver Steatosis. Journal of Clinical Medicine 2025; 14(15) doi: 10.3390/jcm14155417
85
Subrat K. Acharya, Sawan Bopanna. Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?. Journal of Clinical and Experimental Hepatology 2020; 10(5) doi: 10.1016/j.jceh.2020.04.004
86
Javier Diaz-Ferrer, Perapa Chotiprasidhi, Mayra Valdivia-Herrera, Karina Sato-Espinoza. Hepatocellular carcinoma in patients without cirrhosis. World Journal of Gastroenterology 2025; 31(23): 107100 doi: 10.3748/wjg.v31.i23.107100
87
Andrea Marengo, Ramy Ibrahim Kamal Jouness, Elisabetta Bugianesi. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. Clinics in Liver Disease 2016; 20(2) doi: 10.1016/j.cld.2015.10.010
88
Noah J. Daniels, Courtney E. Hershberger, Matthew Kerosky, Chase J. Wehrle, Roma Raj, Nihal Aykun, Daniela S. Allende, Federico N. Aucejo, Daniel M. Rotroff. Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva. International Journal of Molecular Sciences 2024; 25(18) doi: 10.3390/ijms251810144
89
Ekta Dhamija, Shashi Bala Paul, Saurabh Kedia. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma. Indian Journal of Medical Research 2019; 149(1) doi: 10.4103/ijmr.IJMR_1456_17
90
Hae‐Ki Min, Hitoshi Maruyama, Byoung Kuk Jang, Masahiko Shimada, Faridoddin Mirshahi, Shunlin Ren, Youngman Oh, Puneet Puri, Arun J. Sanyal. Suppression of IGF binding protein‐3 by palmitate promotes hepatic inflammatory responses. The FASEB Journal 2016; 30(12) doi: 10.1096/fj.201600427R
91
Feizhou Huang, Huaizheng Liu, Zhao Lei, Zhenzhou Li, Tianyi Zhang, Mingshi Yang, Kefu Zhou, Chuanzheng Sun. Long noncoding RNA CCAT1 inhibits miR‐613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription. Journal of Cellular Physiology 2020; 235(12) doi: 10.1002/jcp.29795
92
Rossella Donghia, Brian Irving Carr, Sezai Yilmaz. Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin. Oncology 2025; 104(2) doi: 10.1159/000545636
93
Chee-Kiat Tan. Peretinoin as an adjuvant therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(11) doi: 10.1080/17474124.2016.1238303
94
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Jin-Woo Lee. Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area. Journal of Liver Cancer 2021; 21(1) doi: 10.17998/jlc.21.1.34
95
Claudia D. Fuchs, Michael Trauner. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nature Reviews Gastroenterology & Hepatology 2022; 19(7) doi: 10.1038/s41575-021-00566-7
96
Jian Wu. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Oncotarget 2106; 7(27) doi: 10.18632/oncotarget.8641
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.